Typically used in Type 2 Diabetes they decrease glucose absorption and increase urinary glucose excretion. FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs.
The purpose of this final rule is to facilitate the electronic transmission of MEC information from FMCSA’s National Registry to the SDLAs. DOT FMCSA-FAA-USCG-Rules-Regulations| Randolph Rosarion M.D. May 10, 2013, the Federal Motor Carrier Safety Administration (FMCSA) published the Medical Examiner’s Certification Integration notice of proposed rulemaking (NPRM) (78 FR 27343). To also view the docket folder for all related documents click Docket ID: FMCSA-2012-0178. On April 23, 2015 FMCSA published the Final Rule which has an effective date of June 22, […]
New diabetes standard for commercial drivers in the works: Land Line Magazine.